Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.27
-0.52 (-5.92%)
At close: Feb 4, 2026, 4:00 PM EST
8.43
+0.16 (1.93%)
After-hours: Feb 4, 2026, 7:56 PM EST

Ginkgo Bioworks Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4705213,3342,85612,355-
Market Cap Growth
-18.24%-84.36%16.75%-76.89%--
Enterprise Value
4313512,6881,61810,698-
Last Close Price
8.279.8267.6067.60332.40-
PS Ratio
2.502.3013.265.9839.37-
PB Ratio
0.840.733.041.657.88-
P/TBV Ratio
0.940.813.451.838.45-
EV/Sales Ratio
2.391.5410.693.3934.09-
Debt / Equity Ratio
0.760.650.220.260.020.04
Asset Turnover
0.140.150.120.210.230.11
Inventory Turnover
---51.9020.30-
Quick Ratio
4.205.455.878.0912.515.50
Current Ratio
4.395.626.118.3812.795.83
Return on Equity (ROE)
-50.02%-60.34%-63.02%-127.52%-180.29%-26.08%
Return on Assets (ROA)
-15.55%-19.67%-21.82%-59.17%-83.23%-12.48%
Return on Capital Employed (ROCE)
-30.90%-37.70%-48.90%-92.20%-94.40%-22.80%
Earnings Yield
-72.24%-104.94%-26.78%-73.72%-14.81%-
FCF Yield
-39.82%-73.31%-10.09%-10.66%-2.51%-
Buyback Yield / Dilution
-7.58%-6.76%-15.75%-23.48%-6.71%-10.95%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q